MedTrace Logo

Severe PID With Lymphoproliferation and Neutropenia

NCT03427593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2026-01-08

No results posted yet for this study

Summary

The purpose of this study is to analyse the phenotype in a sub-population of adults with severe primary immunodeficiency with lymphoproliferation and neutropenia and to decipher the possible pathways involved, especially under the hypothesis of a CTLA4/LRBA schema

Conditions

  • Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)

Interventions

GENETIC

FACS analyses

FACS analyses

GENETIC

Target Sequencing by NGS ( Next-generation sequencing)

Target Sequencing by NGS ( Next-generation sequencing)

GENETIC

Whole Exome Sequencing

Whole Exome Sequencing

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2018-03-13
Completion
2019-12-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427593 on ClinicalTrials.gov